Events


Dr Peter Surman, Chief Scientific Officer, Douglas Pharmaceuticals will discuss their drug repurposing program.

Dr Peter Surman, Chief Scientific Officer, Douglas Pharmaceuticals will discuss their drug repurposing program.

When:
Thursday 25 February, 2021

Where:

COVID LEVEL 1: In Person: SBS Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St. 

COVID LEVEL 2/3: Webinar: Login details to come

RSVP:

Please RSVP to m.jullig@auckland.ac.nz

This month we welcome guest speaker Dr Peter Surman "New Therapeutic Uses for Existing Drugs”, Chief Scientific Officer, Douglas Pharmaceuticals..

We are delighted to invite you on behalf of the IIB to the first forum in our series of networking events for 2021 to be held on Thursday 25 February 2021 from 4.30 for a 5.00 pm start (COVID LEVEL 1). OR 5pm ONLINE start (COVID LEVEL 2/3).

Eighty percent of drugs that enter human clinical testing are never approved for use. This means that for every five drugs that make it into the clinic, there are four that failed to show effectiveness for treating the disease or condition the drug was designed to treat. This high failure rate means there are many existing, partially developed therapeutic candidates with known pharmacology, formulation, and potential toxicity.

However, there is new opportunities for existing drugs or biologics that have been approved by FDA, for novel indications "repositioning" which builds upon previous research and development efforts, so new candidate therapies can be advanced to clinical trials for a new use more quickly than starting from scratch.

Dr Peter Surman, Chief Scientific Officer, will discuss Douglas Pharmaceuticals drug repurposing program.

Douglas Pharmaceuticals is a New Zealand success story – a rapidly expanding pharmaceutical company with a reputation for high manufacturing standards, quality products and outstanding client service.

Parking:

The University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.


The first face-to-face Networking Event for the Bioscience Enterprise Forum- Phil Matheson " The truly magical fungus"

Date: Friday 7 August, 2020
Time: 4.30 for 5.00 pm start
Venue: 
SBS Reception Lounge (Common Room), School of Biological Sciences. There are two entrances, and we will guide you to the entrance around the side
RSVP:
Mia Jullig

I am delighted to invite you on behalf of the Institute for Innovation in Biotechnology (IIB) to the first face-to-face forum in our series of networking events.

This month we welcome guest speaker Phil Matheson from BioFab " The truly magical fungus"

 Plastics are a leading cause of physical pollution on earth. Every year we are introducing millions of tons of durable toxins into our environment. Most of this pollution is related to single-use materials, like Styrofoam

BioFab’s solution is to use new technology to create polystyrene replacements from agricultural waste and mushroom mycelium – the vegetative root structure that produces mushrooms.

Phil expertise in growing mushrooms lead him to the development of mycelium-based technology with BioFab NZ. With a strong background in marketing and strategy, corporate governance, and business analysis, Phil has owned and developed six start-up companies since 2000 and has a particular interest in Biotech, Agritech and Foodtech

Bio-composite - true symbiosis  


Will Barker "Recovering valuable metals from electronic waste"

Date: Friday 25th October 2019
Time: 4.30 for 5.00 pm start
Venue:
SBS Reception Lounge (Common Room), School of Biological Sciences. There are two entrances, and we will guide you to the entrance around the side.


This month we welcome guest speaker Dr Will Barker – CEO/co-founder Mint Innovation.

Following seven years at LanzaTech – Will spent several years scouring New Zealand for the next exciting ‘waste to value’ technology to commercialise. Having reviewed a tonne of really good tech without success – Will went back to business basics to find a commercialisable proposition that maximises the delta between waste input value and product value.  He identified that opportunity in recovering GOLD from electronic waste – founded Mint and has been focused on global deployment of the world’s first biotech solution for this particularly noxious waste stream ever since.

Mint raised just over $5m late last year and has been furiously scaling the precious metal recovery process from lab scale pilot to full commercial scale ahead of global deployment. With a team of 15 primarily technical personnel based in East Tamaki – the company is progressing toward technical and business milestones prior to deploying the first full scale commercial facilities in 2020.

Will is originally a chemist and has experience in IP, venture capital, biotech and cleantech and is keen to share some of the highlights and challenges of working in the New Zealand start up ecosystem for way too long.


David Hemara “Current and future directions of the Dairy Goat Co-operative”

Date: Friday 26 July 2019

Time:

3:00 pm – 4:30 pm Goat Co-operative Symposium

4.30 for 5.00 pm start Networking Drinks and Guest Speaker

Venue: SBS Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St


I am delighted to invite you on behalf of the IIB to the latest in our series of networking events to be held on

Friday 26 July 2019 from 4.30 for a 5.00 pm start.

David Hemara, “Current and future directions of the Dairy Goat Co-operative”.

Prior to the Networking event from 3.00 pm to 4.30 pm

You are invited by David Hemara, CEO Dairy Goat Co-operative and Professor Russel Snell, University of Auckland, to a short symposium on their successful joint research collaboration which is discovering new genetics that will assist in improving the productivity of the NZ Dairy Goat herd.

.

There will be four short presentations by the scientific staff of the Dairy Goat Co-operative and University of Auckland on key aspects of Dairy Goat milk composition, the Dairy Goat on-farm research programme, Dairy Goat behaviour research and progress made towards the identification and implementation of genetics selection in NZ goats.


Anthony Lawler “A simple journey to find a simple treatment for cold sore”

Date: Friday 21 June 2019
Time: 4.30 for 5.00 pm start
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences. There are two entrances, and we will guide you to the entrance around the side.

This month we welcome guest speaker Anthony Lawler is the CEO of HoneyLab “A simple journey to find a simple treatment for cold sore”


I am delighted to invite you on behalf of the IIB to the evening forum in our series of networking:

Guest Speaker: Anthony Lawler “A simple journey to find a simple treatment for cold sore”

Anthony Lawler is the CEO of HoneyLab, who apply Pharmaceutical product development disciplines to develop medical products using honey and other products from bees and their environment. Anthony brings a wealth of experience in the natural health, biotech, food and beverage industries. He has a strong track record of driving strong revenue growth and capital raising with leading companies such as A2 Milk, Vital Foods and more recently Good Heath Products.

Anthony is going to talk about the major study finding NZ K?nuka Honey product is as effective for the treatment for cold sores.  A unique pharmacy-backed trial, one of the largest medical studies of its kind ever undertaken in this country, has shown that honey derived from the New Zealand k?nuka tree is just as effective in healing cold sores as standard pharmaceutical anti-viral treatment- aciclovir cream.


IIB Sabre Celebration and Networking Event- Angus Brown "Commercialising New Zealand's first Brain Drink"

IIB Sabre Celebration and Networking Event- Angus Brown "Commercialising New Zealand's first Brain Drink"

An invitation to a University of Auckland Bioscience Enterprise Friday Forum

Champagne Sabre Celebration: BioPacific Partners sponsors the annual Sabre Champagne celebration to recognise the latest cohort of MBioEnt’s who have just submitted their theses.

Guest Speaker: This month we welcome Angus Brown –“ Commercialising New Zealand's first Brain Drink”

Date: Friday, 17 May 2019

Time: 4:30pm networking drinks and nibbles, 5pm start.

Venue: SBS Reception Lounge (Common Room) at the IIB and SBS entrance to the Thomas Building, 3a Symonds St, School of Biological Sciences.

Parking: University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

Guest Speaker: This month we welcome Angus Brown –“ Commercialising New Zealand's first Brain Drink”

Angus Brown is the CEO and founder of AlphaGen NZ - a food-tech company developing functional foods for the future consumer. Their first product platform is ?repa (M?ori for alpha), a clinically tested natural formula that improves mental clarity, available as liquid beverage, capsules and powder. Their research focuses on NZ natural ingredients and neuroscience and the products are now being exported around the world. Prior to this he worked for central government at New Zealand Food Innovation Network based in the $20m food incubator facility The FoodBowl where he consulted the industry on developing and commercialising new food and beverage products for the export market.

Note we are in the SBS Reception Lounge (Common Room), School of Biological Sciences. There are two entrances, and we will guide you to the entrance around the side.


Paul Manning “A start-up business in a start-up industry”

Paul Manning “A start-up business in a start-up industry”

An invitation to a University of Auckland Bioscience Enterprise Friday Forum

Date: Friday 15 March 2019
Time: 4.30 for 5.00 pm start
Venue: SBS Reception Lounge (Common Room) at the IIB and SBS entrance to the Thomas Building, 3a Symonds St, School of Biological Sciences.
RSVP: By replying "Yes" in the subject line to m.jullig@auckland.ac.nz.


This month we welcome guest speaker
Paul Manning is the co-founder and executive director of Helius Therapeutics, New Zealand’s largest licensed medicinal cannabis company.

Paul Manning is the co-founder and executive director of Helius Therapeutics, New Zealand’s largest licensed medicinal cannabis company, though most of his career has been spent consulting in the design and advertising sector. He founded an agency called Metromedia Group at the age of 22, which went on to become New Zealand’s largest independent agency, before being acquired by Ogilvy & Mather, the world’s largest ad network, in 2007. He then became the executive director of Ogilvy before joining Clemenger Group as managing director of 99. A former EY Young Entrepreneur of the Year, Paul has worked at the highest levels with major agencies and consulted to dozens of New Zealand’s leading brands.

In this talk, Paul will share some of his experiences from co-founding Helius Therapeutics. A start-up business in a start-up industry.


Dr. Sean Simpson “Turning industrial waste gases into low-carbon fuels”.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum

Date: Friday, 26 October 2018

Time: 4:30pm networking drinks and nibbles, 5pm start.

Venue: SBS Reception Lounge (Common Room) at the IIB and SBS entrance to the Thomas Building, 3a Symonds St, School of Biological Sciences.

Parking: University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

Guest Speaker: This month we welcome Dr. Sean Simpson- “Turning industrial waste gases into low-carbon fuels”.

Dr. Sean Simpson is a Co-founder and Chief Scientific Officer of LanzaTech, a global leader in gas fermentation. LanzaTech have pioneered gas fermentation for the production of low carbon fuels and chemicals from low value high volume feedstocks. Dr. Simpson has over 20 publications and 200 patents. He has received a number of awards including the 2015 US Environmental Protection Agency (EPA) Presidential Green Chemistry Award, the 2014 Sanitarium, NZ Innovator of the Year Award, and the 2013 Kea NZ World Class New Zealander in Science Award. He has been a Director of The ICEHOUSE Limited June 2012 – June 2014 and currently as a Director of LanzaTech NZ Ltd. Avertana Ltd, and Dotterel Ltd.  Dr. Simpson holds a PhD from York University, UK, and a Masters degree from Nottingham University, UK.


“That’ll never fly” – A decade of proving them wrong- Dr Michael Lakeman

An invitation to a University of Auckland Bioscience Enterprise Friday Forum "That'll never fly" - A decade of proving them wrong.
Date: Friday, 28 September, 2018

Time: 4:30pm networking drinks and nibbles, 5pm start.

Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.

Guest Speaker:  This month we welcome Dr Michael Lakeman 


Michael Lakeman is a veteran of the bioeconomy, having survived the boom and bust of the first generation biofuels market, to become a key participant in the global push to develop low-carbon sustainable biofuels for aviation.


Dr Michael Lakeman spent over a decade at Boeing, leading the development and execution of their biofuel technology strategy, and leading regional project development across the Pacific rim.   He has served as an advisor and consultant to government, industry, and has led diverse stakeholders to bold action towards common climate goals. Michael received the last ever Botany Ph.D awarded by the University of Washington, Seattle, and earned his B.Sc in Biological Chemistry from the University of Canterbury.

www.lakeman.co

Venue

Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map).

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.


Come and join us to celebrate the success of our 2017 cohort of MBioEnt’s students, and learn to “Network with a Purpose”.

Date: Friday, 23rd March, 2018
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: Fale Pasifika

You are welcome to join us for the second Forum this year on March 23rd at 4.30 with sponsorship from ATEED.

Sabre Champagne celebration: BioPacific Partners sponsors the annual Sabre Champagne celebration to recognise the latest cohort of MBioEnt’s who have just submitted their theses.

Baldwin’s prize: Each year the top student for the IP Law Paper is presented the Baldwin’s prize, this year it will be presented by Harriet Tregonning from Baldwins.

Guest Speaker: Ryan Ashton Managing Director, A Few Quiet Yarns

Ryan has been involved in the New Zealand ICT industry for more than a decade.  During this time, he has held various Sales and Marketing Management positions with some of NZ's leading Software and Systems integrators partnering with global vendors including Salesforce, Google and ClickSoftware.  Ryan is runs the successful and well respected “A Few Quiet Yarns” (AFQY) event series and consulting across the Digital ecosystem, with a focus on customer experience.

Ryan is going to discuss how to “Network with a Purpose”.  It’s the start of the year and there are so many networking events ahead of us but do we really know how to network?  Ryan will give you tips to help your journey of connecting with the right people and make your interactions purposeful.   I recommend that the BioScience Enterprise Alumini attend but also this is a great opportunity for businesses to attend to make the most of every interaction you make, as who knows which conversation could be your businesses game changer, so be prepared for that moment.